Maxitrol Augndropar, dreifa Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

maxitrol augndropar, dreifa

novartis healthcare a/s - neomycinum súlfat; polymyxinum b súlfat; dexamethasonum fosfat - augndropar, dreifa

Myfortic Magasýruþolin tafla 180 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

myfortic magasýruþolin tafla 180 mg

novartis healthcare a/s - mycophenolatum natríum - magasýruþolin tafla - 180 mg

Myfortic Magasýruþolin tafla 360 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

myfortic magasýruþolin tafla 360 mg

novartis healthcare a/s - mycophenolatum natríum - magasýruþolin tafla - 360 mg

Sandomigrin Húðuð tafla 0,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sandomigrin húðuð tafla 0,5 mg

ethyx pharmaceuticals - pizotifenum maleat - húðuð tafla - 0,5 mg

Sandostatin Stungulyf, lausn 100 míkróg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sandostatin stungulyf, lausn 100 míkróg/ml

novartis healthcare a/s - octreotidum inn - stungulyf, lausn - 100 míkróg/ml

Sandostatin Stungulyf, lausn 50 míkróg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sandostatin stungulyf, lausn 50 míkróg/ml

novartis healthcare a/s - octreotidum inn - stungulyf, lausn - 50 míkróg/ml

Sandostatin LAR Stungulyfsstofn og leysir, dreifa 10 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sandostatin lar stungulyfsstofn og leysir, dreifa 10 mg

novartis healthcare a/s - octreotidum inn - stungulyfsstofn og leysir, dreifa - 10 mg